NET PROFIT (x1000 SEK)
EMPLOYEES
GK Pharma ApS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
1,899
|
1,681
|
1,969 |
| Total assets |
14,805
|
15,384
|
15,668 |
| Current assets |
12,989
|
14,826
|
15,399 |
| Current liabilities |
9,454
|
9,813
|
10,806 |
| Equity capital |
3,437
|
3,168
|
1,895 |
| - share capital |
308
|
298
|
299 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
23.2%
|
20.6%
|
12.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
137.4%
|
151.1%
|
142.5% |
| Return on equity (ROE) |
55.3%
|
53.1%
|
103.9% |
| Change turnover |
0
|
0
|
-25,008 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.